148 related articles for article (PubMed ID: 38563879)
1. Inconsistent excipient listings in DailyMed: implications for drug safety.
Kinsella L; Brook J; Briest M; Brook MJ
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38563879
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Determining the accuracy of open-access databases for identifying commonly prescribed oral medications.
Hoover R; Sheth P; Burde A
J Am Pharm Assoc (2003); 2016 Jan; 56(1):37-40. PubMed ID: 26802918
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Therapeutic Classifications of FDA-Approved Prescription Drugs With Boxed Warnings.
Cheng CM; DeLizza C; Kapusnik-Uner J
Ther Innov Regul Sci; 2014 Mar; 48(2):165-172. PubMed ID: 30227516
[TBL] [Abstract][Full Text] [Related]
5. Biologic excipients: Importance of clinical awareness of inactive ingredients.
Ionova Y; Wilson L
PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
[TBL] [Abstract][Full Text] [Related]
7. Gluten content of medications.
Cruz JE; Cocchio C; Lai PT; Hermes-DeSantis E
Am J Health Syst Pharm; 2015 Jan; 72(1):54-60. PubMed ID: 25511839
[TBL] [Abstract][Full Text] [Related]
8. Analyzing excipient-related adverse events in antiseizure drug formulations.
Ionova Y; Peterson T; Wilson L
Epilepsy Res; 2022 Aug; 184():106947. PubMed ID: 35661571
[TBL] [Abstract][Full Text] [Related]
9. Quantifying the 'hidden' lactose in drugs used for the treatment of gastrointestinal conditions.
Eadala P; Waud JP; Matthews SB; Green JT; Campbell AK
Aliment Pharmacol Ther; 2009 Mar; 29(6):677-87. PubMed ID: 19035974
[TBL] [Abstract][Full Text] [Related]
10. Harmful excipients in medicines for neonates in Spain.
Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
[TBL] [Abstract][Full Text] [Related]
11. Anaphylaxis to Excipients in Current Clinical Practice: Evaluation and Management.
Bruusgaard-Mouritsen MA; Nasser S; Garvey LH; Krantz MS; Stone CA
Immunol Allergy Clin North Am; 2022 May; 42(2):239-267. PubMed ID: 35469617
[TBL] [Abstract][Full Text] [Related]
12. The extra-phosphate intestinal load from medications: is it a real concern?
Cupisti A; Moriconi D; D'Alessandro C; Verde F; Marchini M; Saba A; Egidi MF
J Nephrol; 2016 Dec; 29(6):857-862. PubMed ID: 27084800
[TBL] [Abstract][Full Text] [Related]
13. Adverse Event extraction from Structured Product Labels using the Event-based Text-mining of Health Electronic Records (ETHER) system.
Pandey A; Kreimeyer K; Foster M; Dang O; Ly T; Wang W; Forshee R; Botsis T
Health Informatics J; 2019 Dec; 25(4):1232-1243. PubMed ID: 29359620
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of a drug allergy registry-based excipient allergy database and call for universal mandatory drug ingredient disclosure: the case of PEG.
Kan AKC; Chiang V; Saha C; Au EYL; Li PH
Front Allergy; 2023; 4():1331036. PubMed ID: 38292585
[TBL] [Abstract][Full Text] [Related]
15. Design of mobile and website health application devices for drug tolerability in hereditary fructose intolerance.
Izquierdo-García E; Lázaro-Cebas A; Montero Pastor B; Such Díaz A; Álvaro-Alonso EA; López Guerra L; Escobar-Rodríguez I
Orphanet J Rare Dis; 2024 Jan; 19(1):12. PubMed ID: 38183105
[TBL] [Abstract][Full Text] [Related]
16. Effect of excipients on the stability of levothyroxine sodium tablets.
Das Gupta V; Odom C; Bethea C; Plattenburg J
J Clin Pharm Ther; 1990 Oct; 15(5):331-6. PubMed ID: 2289935
[TBL] [Abstract][Full Text] [Related]
17. Immediate Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review.
Caballero ML; Quirce S
J Investig Allergol Clin Immunol; 2020 Apr; 30(2):86-100. PubMed ID: 32327401
[TBL] [Abstract][Full Text] [Related]
18. Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions.
Caballero ML; Krantz MS; Quirce S; Phillips EJ; Stone CA
J Allergy Clin Immunol Pract; 2021 Aug; 9(8):2968-2982. PubMed ID: 33737254
[TBL] [Abstract][Full Text] [Related]
19. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
[TBL] [Abstract][Full Text] [Related]
20. Identification of phthalates in medications and dietary supplement formulations in the United States and Canada.
Kelley KE; Hernández-Díaz S; Chaplin EL; Hauser R; Mitchell AA
Environ Health Perspect; 2012 Mar; 120(3):379-84. PubMed ID: 22169271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
